Samidorphan
「Samidorphan」熱門搜尋資訊
「Samidorphan」文章包含有：「AReviewofSamidorphan」、「HomepageforLYBALVI®(olanzapineandsamidorphan...」、「OlanzapineSamidorphaninYoungAdultsWith...」、「OlanzapineSamidorphan」、「Samidorphan」、「Samidorphan」、「Samidorphanforthetreatmentofweightgainassociated...」、「Samidorphan」、「Samidorphan:Uses」、「Samidorphanolanzapinecombinationtherapyfor...」
查看更多
A Review of Samidorphan
https://www.ncbi.nlm.nih.gov
As discussed above, SAM is a novel opioid-system modulator that acts as an opioid antagonist at MOR in vivo. Although chemically derived from ...
Home page for LYBALVI® (olanzapine and samidorphan ...
https://www.lybalvi.com
Indication: LYBALVI ® is used in adults to treat manic or mixed episodes that happen with bipolar 1 disorder, either alone for short-term (acute) or maintenance ...
OlanzapineSamidorphan in Young Adults With ...
https://pubmed.ncbi.nlm.nih.go
Olanzapine/Samidorphan in Young Adults With Schizophrenia, Schizophreniform Disorder, or Bipolar I Disorder Who Are Early in Their Illness: ...
OlanzapineSamidorphan
https://pubmed.ncbi.nlm.nih.go
Samidorphan, which was developed by Alkermes, is an opioid receptor antagonist that has been co-formulated with olanzapine into a single-dose oral tablet to ...
Samidorphan
https://en.wikipedia.org
Samidorphan has been investigated for the treatment of alcoholism and cocaine addiction by its developer, Alkermes, showing similar efficacy to naltrexone but ...
Samidorphan
https://www.sciencedirect.com
Samidorphan (SAM), 3-carboxamido-4-hydroxy naltrexone, is a relatively new opioid system modulator that has a high affinity for binding with μ‐opioid, κ‐opioid, ...
Samidorphan for the treatment of weight gain associated ...
https://pubmed.ncbi.nlm.nih.go
Samidorphan (SAM) is a μ-opioid receptor antagonist and it can reduce the weight gain associated with OLZ. A combination of OLZ and SAM (OLZ/SAM) has been ...
Samidorphan
https://pubchem.ncbi.nlm.nih.g
Samidorphan | C21H26N2O4 | CID 11667832 - structure, chemical names, physical and chemical properties, classification, patents, literature, ...
Samidorphan: Uses
https://go.drugbank.com
Samidorphan is a novel opioid-system modulator, similar to naltrexone, that functions primarily as a μ-opioid receptor antagonist in vivo ...
Samidorphanolanzapine combination therapy for ...
https://www.ncbi.nlm.nih.gov
Samidorphan has a bioavailability of 69% and a half-life of around 7–10 h while olanzapine has a half-life of 35–52 h which makes it a suitable companion to ...